Nelonicline

Nelonicline Suppliers list
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: Cool Pharm, Ltd  
Tel: 021-60455363 18019463053
Email: sales@coolpharm.com
Company Name: Shanghaizehan biopharma technology co., Ltd.  
Tel: 021-61350663 13052117465
Email: sales@zehanbiopharma.com
Company Name: ShangHai Angti Biotechnology Co., Ltd.  
Tel: 13764913901
Email: info@angtibio.com
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com

Nelonicline manufacturers

  • Nelonicline
  • Nelonicline pictures
  • $2500.00
  • 2026-07-15
  • CAS:1026134-63-3
  • Purity:
  • Supply Ability: 10g
Nelonicline Basic information
Product Name:Nelonicline
Synonyms:Nelonicline;ABT-126;1-Azatricyclo[3.3.1.13,7]decane, 4-[(5-phenyl-1,3,4-thiadiazol-2-yl)oxy]-, stereoisomer;2-(((3R,4r,5S,7s)-1-azaadamantan-4-yl)oxy)-5-phenyl-1,3,4-thiadiazole;Nelonicline(ABT-126);2-((1r,3R,4s,5S,7s)-1-azaadamantan-4-yloxy)-5-phenyl-1,3,4-thiadiazole
CAS:1026134-63-3
MF:C17H19N3OS
MW:313.42
EINECS:
Product Categories:
Mol File:1026134-63-3.mol
Nelonicline Structure
Nelonicline Chemical Properties
Boiling point 460.2±55.0 °C(Predicted)
density 1.35±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility Soluble in DMSO
form Solid
pka7.78±0.40(Predicted)
color White to off-white
Safety Information
MSDS Information
Nelonicline Usage And Synthesis
UsesNelonicline (ABT-126) is an orally active and selective α7 nicotinic receptor agonist with high affinity to α7 nAChRs in human brain (Ki=12.3 nM). Nelonicline is used for the research of shizophrenia and Alzheimer's disease[1][2][3].
References[1] Zhang D, et al. α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage. Mov Disord. 2015;30(14):1901-1911. DOI:10.1002/mds.26453
[2] Haig G, et al. The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study. Neuropsychopharmacology. 2016;41(12):2893-2902. DOI:10.1038/npp.2016.101
[3] Gault LM, et al. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension. Alzheimers Res Ther. 2016;8(1):44. Published 2016 Oct 18. DOI:10.1186/s13195-016-0210-1
Nelonicline Preparation Products And Raw materials
Tag:Nelonicline(1026134-63-3) Related Product Information
Nelonicline QZDCYUCETTWCMO-UHFFFAOYSA-N 2-((1R,3R,4R,7S)-1-azaadamantan-4-yloxy)-5-phenyl-1,3,4-thiadiazole ABT-126 citrate 3-(2,4-dimethoxybenzylidene)anabaseine N-(2,5-dichlorophenyl)-4-(furan-2-yl)-2-methyl-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-carboxamide